IP Finance to Hold Seminar on UNCITRAL Issues Regarding IP and Secured Financing

By: Ian McClure

I have posted previously on the continued discussions by the United Nations Commission on International Trade Law (UNCITRAL) Working Group VI (Security Interests) regarding issues in intellectual property that are raised by the inconsistencies between intellectual property law and secured transactions law. These issues have become the focal point for this Group as they attempt to put together an IP addendum to the Legislative Guide on Secured Transactions, which is to be adopted by member states. IP Finance has kept up with the ... Read More

Categories: Portfolio Potential

Morgan Stanley Does Large IP Securitization Deal

By: Ian McClure

Could this be a resurgence of IP securitization?   Financial Times has reported a large IP securitization deal worth $250M executed by Morgan Stanley with Vertex Pharmaceuticals.  Investors' return will be based on milestone royalty payments received from sales of a drug that hasn't even been approved yet.   Before the recession, securitizing intangibles was becoming somewhat popular.  Many are aware of the Dunkin Donuts deal that hit headlines everywhere.  Still, these deals, along with most other deals, have dried up.  The Vertex deal shows ... Read More

Categories: Investment Intelligence, Monetizing IP, Portfolio Potential